Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: A randomized, controlled trial

Journal of Allergy and Clinical Immunology: In Practice

Volumn 1, Issue 6, 2013, Pages 639-648.e8

  Syk, Jörgen ^a   Malinovschi, Andrei ^b   Johansson, Gunnar ^b   Undén, Anna Lena ^a   Andreasson, Anna ^a,c   Lekander, Mats ^a,c   Alving, Kjell ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Asthma; Atopy; Breath test; Corticosteroid; Exacerbation; Leukotriene receptor antagonist; Primary care; Quality of life

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; NITRIC OXIDE;

ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA CONTROL QUESTIONNAIRE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; FEMALE; FRACTION OF EXHALED NITRIC OXIDE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI ASTHMA QUALITY OF LIFE QUESTIONNAIRE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT PARAMETERS; SCORING SYSTEM; ADOLESCENT; ASTHMA; BREATH ANALYSIS; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BREATH TESTS; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; NITRIC OXIDE; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887021419     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.07.013     Document Type: Article

References (40)

1. Lisspers K., Stallberg B., Hasselgren M., Johansson G., Svardsudd K. Quality of life and measures of asthma control in primary health care. JAsthma 2007, 44:747-751.
2. Stallberg B., Lisspers K., Hasselgren M., Janson C., Johansson G., Svardsudd K. Asthma control in primary care in Sweden: a comparison between 2001 and 2005. Prim Care Respir J 2009, 18:279-286.
3. Thomas M., von Ziegenweidt J., Lee A.J., Price D. High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study. JAllergy Clin Immunol 2009, 123:116-121.e10.
4. Aaron S.D., Vandemheen K.L., Boulet L.P., McIvor R.A., Fitzgerald J.M., Hernandez P., et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ 2008, 179:1121-1131.
5. Alving K., Malinovschi A. Basic aspects of exhaled nitric oxide. Eur Respir Monograph 2010, 49:1-31.
6. Dweik R.A., Boggs P.B., Erzurum S.C., Irvin C.G., Leigh M.W., Lundberg J.O., et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011, 184:602-615.
7. de Jongste J.C., Carraro S., Hop W.C., Baraldi E. Daily telemonitoring of exhaled nitric taoxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med 2009, 179:93-97.
8. Fritsch M., Uxa S., Horak F., Putschoegl B., Dehlink E., Szepfalusi Z., et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol 2006, 41:855-862.
9. Pijnenburg M.W., Bakker E.M., Hop W.C., De Jongste J.C. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005, 172:831-836.
10. Shaw D.E., Berry M.A., Thomas M., Green R.H., Brightling C.E., Wardlaw A.J., et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007, 176:231-237.
11. Smith A.D., Cowan J.O., Brassett K.P., Herbison G.P., Taylor D.R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. NEngl J Med 2005, 352:2163-2173.
12. Szefler S.J., Mitchell H., Sorkness C.A., Gergen P.J., O'Connor G.T., Morgan W.J., et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008, 372:1065-1072.
13. Gibson P.G. Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies. Clin Exp Allergy 2009, 39:478-490.
14. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005, 171:912-930.
15. Juniper E.F., Guyatt G.H., Cox F.M., Ferrie P.J., King D.R. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999, 14:32-38.
16. Tibblin G., Tibblin B., Peciva S., Kullman S., Svardsudd K. "The Goteborg quality of life instrument"-an assessment of well-being and symptoms among men born 1913 and 1923. Methods and validity. Scand J Prim Health Care Suppl 1990, 1:33-38.
17. Juniper E.F., O'Byrne P.M., Ferrie P.J., King D.R., Roberts J.N. Measuring asthma control. Clinic questionnaire or daily diary?. Am J Respir Crit Care Med 2000, 162:1330-1334.
18. Olin A.C., Rosengren A., Thelle D.S., Lissner L., Bake B., Toren K. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 2006, 130:1319-1325.
19. Taylor D.R., Pijnenburg M.W., Smith A.D., De Jongste J.C. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006, 61:817-827.
20. Reddel H.K., Taylor D.R., Bateman E.D., Boulet L.P., Boushey H.A., Busse W.W., et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009, 180:59-99.
21. Syk J., Unden A.L., Alving K. Relationship between exhaled nitric oxide and IgE sensitisation in patients with asthma: influence of steroid treatment. Clin Respir J 2009, 3:143-151.
22. Petsky H.L., Cates C.J., Lasserson T.J., Li A.M., Turner C., Kynaston J.A., et al. Asystematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012, 67:199-208.
23. Powell H., Murphy V.E., Taylor D.R., Hensley M.J., McCaffery K., Giles W., et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet 2011, 378:983-990.
24. Ehrs P.O., Nokela M., Stallberg B., Hjemdahl P., Wikstrom Jonsson E. Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting. Chest 2006, 129:925-932.
25. Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002, 360:1715-1721.
26. van der Valk R.J., Baraldi E., Stern G., Frey U., de Jongste J.C. Daily exhaled nitric oxide measurements and asthma exacerbations in children. Allergy 2012, 67:265-271.
27. Dougherty R.H., Fahy J.V. Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy 2009, 39:193-202.
28. Ferreira A., Williams Z., Donninger H., van Schalkwyk E.M., Bardin P.G. Rhinovirus is associated with severe asthma exacerbations and raised nasal interleukin-12. Respiration 2002, 69:136-142.
29. Oborne J., Mortimer K., Hubbard R.B., Tattersfield A.E., Harrison T.W. Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Am J Respir Crit Care Med 2009, 180:598-602.
30. Ihre E., Gyllfors P., Gustafsson L.E., Kumlin M., Dahlen B. Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge. Eur Respir J 2006, 27:1152-1159.
31. Price D., Musgrave S.D., Shepstone L., Hillyer E.V., Sims E.J., Gilbert R.F., et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. NEngl J Med 2011, 364:1695-1707.
32. Kloepfer K.M., DeMore J.P., Vrtis R.F., Swenson C.A., Gaworski K.L., Bork J.A., et al. Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16. Ann Allergy Asthma Immunol 2011, 106:252-257.
33. Fritscher L.G., Rodrigues M.T., Zamel N., Chapman K.R. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med 2009, 103:296-300.
34. Calhoun W.J., Ameredes B.T., King T.S., Icitovic N., Bleecker E.R., Castro M., et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA 2012, 308:987-997.
35. Holgate S., Bisgaard H., Bjermer L., Haahtela T., Haughney J., Horne R., et al. The Brussels Declaration: the need for change in asthma management. Eur Respir J 2008, 32:1433-1442.
36. Hewitt R.S., Modrich C.M., Cowan J.O., Herbison G.P., Taylor D.R. Outcomes using exhaled nitric oxide measurements as an adjunct to primary care asthma management. Prim Care Respir J 2009, 18:320-327.
37. Travers J., Marsh S., Williams M., Weatherall M., Caldwell B., Shirtcliffe P., et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?. Thorax 2007, 62:219-223.
38. Patelis A., Gunnbjornsdottir M., Malinovschi A., Matsson P., Onell A., Hogman M., et al. Population-based study of multiplexed IgE sensitization in relation to asthma, exhaled nitric oxide, and bronchial responsiveness. JAllergy Clin Immunol 2012, 130:397-402.e2.
39. Zeiger R.S., Schatz M., Zhang F., Crawford W.W., Kaplan M.S., Roth R.M., et al. Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. JAllergy Clin Immunol 2011, 128:412-414.
40. Berry M., Morgan A., Shaw D.E., Parker D., Green R., Brightling C., et al. Pathological features and inhaled corticosteroid response of eosinophilic and noneosinophilic asthma. Thorax 2007, 62:1043-1049.